Form4.ai tracks every SEC insider trade in real time. See every LXEO insider filing with a free account — no card.
See every LXEO insider filing — free account, no card.
Free accountLexeo Therapeutics, Inc. (LXEO) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $43K. Most recent filing: Sept. 28, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Sep 28, 2026 SEC filing | Bhalla Narinder Pal Chief Medical Officer | Grant / award | $9,713 | — |
| Sep 28, 2026 SEC filing | Townsend Richard Nolan Chief Executive Officer | Grant / award | $6,097 | — |
| Sep 28, 2026 SEC filing | Otero Jose Manuel Chief Operating Officer | Grant / award | $5,579 | — |
Create a free account to see all 7 LXEO filings from the last 90 days. No card needed.
Create free accountWant LXEO insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.